[ Price : $8.95]
FDA extends by 30 days the comment period on a request for information entitled AI-Enabled Optimization of Early-Phase Clinical Tr...[ Price : $8.95]
Eli Lilly says it is acquiring three vaccine developers in deals worth up to $3.8 billion combined, expanding its push into infect...[ Price : $8.95]
FDA cites Dabur India Limited for significant manufacturing and data integrity violations at an over-the-counter drug manufacturin...[ Price : $8.95]
Researchers say manufacturers could make better use of predetermined change control plans for AI-enabled medical devices.[ Price : $8.95]
A Cooley legal analysis notes that FDA and federal prosecutors are signaling a tougher stance on failures to report patient safety...[ Price : $8.95]
FDA warns Alsip, IL-based GC America about CGMP violations in its production of finished drugs.[ Price : $8.95]
FDA extends its review of an AstraZeneca NDA for camizestrant, an experimental breast cancer therapy, after requesting additional ...[ Price : $8.95]
Corcept Therapeutics plans to resubmit its NDA for relacorilant as a treatment for patients with Cushings syndrome, following addi...